View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 15, 2018

Boston Scientific and CÚRAM plan to develop heart surgery devices

Boston Scientific has partnered with Ireland-based CÚRAM, the SFI Research Centre for Medical Devices at National University Ireland (NUI) Galway, to advance medical devices for cardiovascular (CV) surgeries.

Boston Scientific has partnered with Ireland-based CÚRAM, the SFI Research Centre for Medical Devices at National University Ireland (NUI) Galway, to advance medical devices for cardiovascular (CV) surgeries.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The partners plan to develop new devices that will support minimally invasive procedures performed to treat aneurysms and aortic valve repair.

Currently, valve repair procedures involving the use of a catheter to insert a replacement valve are being frequently performed and are said to minimise the risk of surgery for patients.

The new devices will be designed to further decrease this risk, while also improving patient outcomes.

“The partners plan to develop new devices that will support minimally invasive procedures performed to treat aneurysms and aortic valve repair.”

Under the project, which will be led by CÚRAM principal investigator (PI) Dr Niamh Hynes, the organisations will combine their respective expertise and experience in clinical, biomedical and scientific research.

CÚRAM scientific director Abhay Pandit said: “This unique, multi-disciplinary, specialist environment is key to CÚRAM’s success in developing strong programmes of work with our industry partners; in this case bringing substantial investment from Boston Scientific.

“This project is in addition to three other ongoing research projects with Boston Scientific.”

The SFI Research Centre is also conducting a preclinical assessment of a catheter device to support muscle and vascular regeneration in critical limb ischemia.

In another project, CÚRAM and Boston Scientific have partnered to create a new implantable electrical stimulation device that will improve cardiovascular circulation.

Pandit added: “CÚRAM’s goal is to establish long-term strategic relationships with our industry partners, to complete projects that advance medical device technologies and inventions and convert these into products and services that benefit the patient.”

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network